Ropes & Gray Represents Athyrium Capital in $2 bn Healthcare Fund
Ropes & Gray acted as counsel to Athyrium Capital Management in the formation of its $2 billion healthcare fund, Athyrium Opportunities Fund III. The closing of the fund was announced on Dec. 4, with approximately $2.025 billion from a global investor base comprises more than 45 institutions, including public and private pension funds, endowments, foundations and sovereign wealth funds.
Athyrium Capital Management, LP ("Athyrium Capital") is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium Capital manages funds with committed capital in excess of $3.7 billion.
Athyrium Opportunities Fund III seeks to make investments of $20 million to $300 million in commercial-stage healthcare companies in North America, Europe, Asia and Australia. The Fund invests across the healthcare sector including pharmaceuticals, medical products, diagnostics, healthcare services and healthcare information technology.
The Ropes & Gray team was led by hedge funds partner Jessica O’Mary and included tax partner Adam Greenwood, corporate associate Christian Vareika and tax & benefits associate Kathryn Seevers.